While we identified APOBEC3G (A3G) dysregulation in SII ESCA, its role in imparting significant somatic hypermutations is currently unknown as A3G has been traditionally studied for its role in either providing immunity against a plethora of viruses or regulating tumour immune landscape [43, 45, 46]. The gene discussed is APOBEC3G; the disease is neoplasm.